iSpecimen Inc.ISPC
Price (close)
$1.25
Market cap
$1.9M
P/E
—
Revenue (TTM)
$466,302
Net income
-$11.4M
Dividend yield
—
1-year total return
-97.7%
Net margin
-2449.0%
Revenue growth
-92.1%
Debt / equity
—
What iSpecimen Inc. does.
mission is to accelerate life science research, discovery and development with a global marketplace platform that connects researchers
to subjects, specimens, and associated data. Our vision is to create an “Amazon-like” global Marketplace of patients, biospecimens,
and data for research to improve the quality of human life. We implement employee programs that foster a company culture predicated on
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $8.2M | $11.1M | $10.4M | $9.9M | $9.3M | $1.9M |
| Net income | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| Free cash flow | -$288,806 | -$10.7M | -$6.0M | -$5.8M | -$8.3M | -$4.2M |
More on ISPC.
- iSpecimen Inc. summary
- iSpecimen Inc. financial statements
- iSpecimen Inc. key metrics
- iSpecimen Inc. health scores and style box
- iSpecimen Inc. earnings
- iSpecimen Inc. dividends
- iSpecimen Inc. valuation
- iSpecimen Inc. ownership and insiders
- iSpecimen Inc. peers
Figures from iSpecimen Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.